(Q41729461)

8 October 2017

title

Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy (English)

1 reference

8 October 2017

Chou RH

1

1 reference

8 October 2017

Wilder RB

2

1 reference

8 October 2017

Ji M

3

1 reference

8 October 2017

Ryu JK

4

1 reference

8 October 2017

Leigh BR

5

1 reference

8 October 2017

Earle JD

6

1 reference

8 October 2017

Doggett RL

7

1 reference

8 October 2017

Kubo HD

8

1 reference

8 October 2017

Roach M

9

1 reference

8 October 2017

deVere White RW

10

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

International Journal of Radiation Oncology Biology Physics

8 October 2017

published in

1 reference

8 October 2017

volume

47

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

115-119

1 reference

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Biochemical disease-free survival following 125I prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Optimization of the oblique angles in the treatment of prostate cancer during six-field conformal radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

The Baylor College of Medicine experience with gold seed implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900422-3

7 January 2021

10.1016/S0360-3016(00)00422-3

Identifiers

DOI

1 reference

8 October 2017

1 reference